Type-1 Pericytes Participate in Fibrous Tissue Deposition in Aged Skeletal Muscle.
American journal of physiology. Cell physiology (2013)
The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors.
Current pharmaceutical biotechnology, 14, 300-12 (2013)
Role of pericytes in skeletal muscle regeneration and fat accumulation.
Stem cells and development, 22, 2298-314 (2013)
PET/CT illustration of metastatic breast cancer to the left mandibular foramen.
Clinical nuclear medicine, 38, 385-6 (2013)
Skeletal muscle pericyte subtypes differ in their differentiation potential.
Stem cell research, 10, 67-84 (2013)
Skeletal muscle neural progenitor cells exhibit properties of NG2-glia.
Experimental cell research, 319, 45-63 (2013)
A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13R?2 tumor-restricted biomarker.
Neuro-oncology, 14, 1239-53 (2012)
EphrinA1 is released in three forms from cancer cells by matrix metalloproteases.
Molecular and cellular biology, 32, 3253-64 (2012)
Evolution of a ureteric stone from the renal pelvis to the ureter on skeletal scintigraphy with CT correlation.
Clinical nuclear medicine, 37, 188-9 (2012)
Molecular Targeted ?-Particle Therapy for Oncologic Applications.
AJR. American journal of roentgenology, 203, 253-60 (2014)
Type-2 pericytes participate in normal and tumoral angiogenesis.
American journal of physiology. Cell physiology, 307, C25-38 (2014)
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
Carcinogenesis, 35, 1491-9 (2014)
Somatostatin receptor molecular imaging for metastatic intracranial hemangiopericytoma.
Clinical nuclear medicine, 38, 984-7 (2013)
On the use of [18F]DOPA as an imaging biomarker for transplanted islet mass.
Annals of nuclear medicine, 28, 47-52 (2014)